Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price reached a new 52-week low during trading on Friday . The stock traded as low as GBX 54.75 ($0.67) and last traded at GBX 57 ($0.70), with a volume of 62242 shares changing hands. The stock had previously closed at GBX 74 ($0.91).
Arecor Therapeutics Stock Performance
The stock has a 50 day simple moving average of GBX 73.65 and a 200 day simple moving average of GBX 81.95. The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51. The company has a market cap of £21.52 million, a price-to-earnings ratio of -203.57 and a beta of -0.18.
About Arecor Therapeutics
Arecor Therapeutics plc is a biopharmaceutical company transforming patient care by bringing innovative medicines to market. Through the enhancement of existing medicines using our Arestat™ technology, we are developing a broad portfolio of therapies as part of our proprietary pipeline and through partnerships with leading pharmaceutical and biotech companies.
Featured Articles
- Five stocks we like better than Arecor Therapeutics
- How to Most Effectively Use the MarketBeat Earnings Screener
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What is a buyback in stocks? A comprehensive guide for investors
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What is a Secondary Public Offering? What Investors Need to Know
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
